Summary of Classification and Labelling
Notified classification and labelling
General Information
603-188-8 |
2-oxo-N-(3,3,5-trimethyl-5-{[2,4,6-trioxo-3,5-bis({1,3,3-trimethyl-5-[(2-oxoazepane-1-carbonyl)amino]cyclohexyl}methyl)-1,3,5-triazinan-1-yl]methyl}cyclohexyl)azepane-1-carboxamide; 2-oxo-N-(3,3,5-trimethyl-5-{[2,4,6-trioxo-3-({1,3,3-trimethyl-5-[(2-oxoazepane-1-carbonyl)amino]cyclohexyl}methyl)-5-({1,3,3-trimethyl-5-[2,4,6-trioxo-3,5-bis(3,3,5-trimethyl-5-{[(2-oxoazepane-1-carbonyl)amino]methyl}cyclohexyl)-1,3,5-triazinan-1-yl]cyclohexyl}methyl)-1,3,5-triazinan-1-yl]methyl}cyclohexyl)azepane-1-carboxamide |
127184-53-6 |
Notified classification and labelling according to CLP criteria
STOT RE 1 |
H372
(other:local eff...)
(inhalation)
|
H372
|
|
GHS08 Dgr
|
|
|
|
|
21 |
|
View details
|
STOT RE 1 |
H372
(Respiratory tra...)
|
H372
|
|
GHS08 Dgr
|
|
|
|
|
13 |
|
View details
|
Number of Aggregated Notifications: 2